What Endocanna Health does

Endocanna Health is a Burbank, California-based biotechnology research company founded in 2017 that develops DNA testing products and cannabinoid-based wellness products, using genomic analysis of the endocannabinoid system (ECS) to personalize cannabis and adjunctive therapy recommendations. The company serves both end consumers via direct-to-consumer testing and a line of branded CBD tinctures and softgels (priced $69.95-$99), and healthcare providers, clinics, and consumer brands via its Lab-in-a-Box white-label testing platform. As of the most recent disclosures, the company reports 7,000+ customers across 16 countries, with named partners including Metrodora Institute, Bella Vita Clinics, and individual clinicians such as Dr. Jennifer Berman.

The technical core is the MyDNA.live platform and its EndoDNA Test, which genotype ECS-relevant variants and map them to product and dosing recommendations. The platform is built on Google Cloud, leveraging DeepVariant for variant calling, Vertex AI for model deployment, and Med-PaLM 2 for medical-language interpretation, surfaced through the MyDNA Copilot generative assistant and its 'Chat with Your Patient's DNA' feature. Endocanna operates a CLIA-certified, CAP-accredited laboratory and uses an FDA-approved DNA collection device, providing a regulated infrastructure for clinical-grade testing. Its IP portfolio includes US Patent 10,654,789B2 and two PCT applications covering its genotype-to-product matching methodology.

Endocanna's monetization combines per-test consumer revenue, white-label B2B licensing through Lab-in-a-Box, and recurring sales of branded cannabinoid SKUs. Research and commercial collaborations with Harvard McLean Hospital, Wayne State University, University of Colorado Boulder, CHU Montréal (CHUM), Google, and TrueBinding (TB006 Alzheimer's program) anchor the company's scientific positioning. No funding rounds have been publicly disclosed, indicating the company has operated either via bootstrapping or undisclosed private capital, and revenue figures are not publicly reported.

Name

Endocanna Health

Legal name

Endocanna Health, Inc.

Website

https://endocannahealth.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Endocanna Health is a Burbank, California-based biotechnology company founded in 2017 that develops AI-powered ECS genetic testing (MyDNA.live, EndoDNA Test) and personalized cannabinoid products for consumers, clinicians, and white-label partners across 16 countries.

Ownership category

akta.pro rank

Product category

Genomic Wellness Software

NAICS

Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medicinal and Botanical Manufacturing (325411)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Precision genomic testing
• Cannabinoid DNA analysis
• AI genetic intelligence
• Pharmacogenomics software
• Endocannabinoid wellness

Headquarters

HQ city

Burbank

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

1. DNA Genetic Testing Services: Provides genetic testing kits and analysis services to healthcare providers and individuals. Generates revenue through sale of EndoDNA test kits and analysis reports delivered through the MyDNA.live portal.
2. CBD Product Sales: Sells proprietary CBD products including tinctures and softgels directly to consumers through e-commerce storefront.
3. White-Label Lab-in-a-Box Solution: Licenses branded genetic testing infrastructure to partners including customized test kits, laboratory partnerships, and operational platform. Partners can launch their own branded DNA testing services.
4. Menopause Biotype Genetic Test: Specialized genetic test developed by Dr. Jennifer Berman for menopause symptom management and treatment planning.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Endocanna Health develops and operates an AI-driven genomic analysis platform (MyDNA.live and MyDNA Copilot) that delivers personalized DNA-based wellness reports, including endocannabinoid and pharmacogenomic insights, to healthcare providers and consumers. The company also sells proprietary CBD products (tinctures, softgels) directly to consumers through an e-commerce storefront, and licenses a turnkey white-label genetic testing business solution (Lab-in-a-Box) to partners.

Product overview

Endocanna Health offers a portfolio of AI-driven genomic wellness products and services centered on its patented MyDNA.live platform and MyDNA Copilot AI assistant. The core offerings include the EndoDNA genetic test providing personalized cannabinoid and terpene recommendations, the Menopause Biotype Genetic Test, and TB006 Genetic Screening. The company also provides business solutions through its Lab-in-a-Box white-label program and MyDNA Integration service. Additionally, Endocanna Health sells direct-to-consumer CBD products including tinctures and softgels. The platform leverages pharmacogenomics, metabolic function analysis, and generative AI to deliver precision health recommendations.

Differentiator

Problem solved

Functional benefit

Products and services

• MyDNA.live Platform Patented provider portal platform for comprehensive genetic analysis, providing detailed genetic profiles, wellness predisposition insights, evidence-based recommendations, workflow integration, and documentation tools for healthcare providers and practitioners.
• MyDNA Copilot AI-powered genetic intelligence partner with natural language interface for exploring genetic insights, wellness plan development, and continuous learning from latest genomic research, powered by Google DeepVariant, Vertex AI, and Med-PaLM 2.
• EndoDNA Test Patented DNA test delivering personalized cannabinoid and terpene recommendations tailored to unique genetic profiles, with 60+ detailed endocompatibility reports including drug interaction alerts, terpene profiling, and endocannabinoid genotype insights.
• Menopause Biotype Genetic Test

Quantifiable outcome

• Supports precision wellness across 7,000+ customers in 16 countries
• +1 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Harvard University (McLean Hospital)coreStrategic or Co-development PartnerClinical research collaborations with Harvard's McLean Hospital including multiple clinical trials. Powers genetic research studies at the institution, contributing to breakthroughs in precision wellness and personalized medicine.
• Wayne State UniversitycoreStrategic or Co-development PartnerResearch partnerships for cutting-edge genomic and health research collaborations, contributing to clinical trials and personalized medicine breakthroughs.
• University of Colorado BouldercoreStrategic or Co-development PartnerAcademic research partnership for genomic and health research collaborations at the university level.
• Centre Hospitalier de l'Université de Montréal (CHUM)coreStrategic or Co-development PartnerInternational research collaboration with leading Canadian healthcare institution for genomic and health research.
• Google (DeepVariant, Vertex AI, Med-PaLM 2, Google Cloud Platform)coreTechnology or IntegrationTechnology partnership utilizing Google's AI infrastructure including DeepVariant for genetic analysis, Vertex AI, Med-PaLM 2 for natural language processing, and Google Cloud Platform for hosting MyDNA Copilot.
• TrueBinding, Inc.minorStrategic or Co-development PartnerPartnership for TB006 Genetic Screening test - analyzes individual's LGALS3 genetics to determine candidacy for TrueBinding's experimental Alzheimer's disease therapy under FDA's Expanded Patient Therapy program.
• Dr. Jennifer Berman / Metrodora InstitutecoreStrategic or Co-development PartnerPartnership with renowned women's health specialist Dr. Jennifer Berman for development and marketing of Menopause Biotype Genetic Test. Metrodora Institute is a prominent health brand relationship for women's health genetic testing.
• Bella Vita ClinicscoreChannel Partner/ Reseller/ DistributorProminent health brand relationship providing access to wellness clinic network for genetic testing services and wellness products.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ancestry: Largest consumer DNA testing company. Comparable on DTC genetic testing infrastructure and provider-side portal delivery, though focused on ancestry rather than health and wellness.
• Viome: Personalized wellness company combining DNA, microbiome, and AI-driven health recommendations. Comparable as a DTC wellness platform that bundles genetic insights with consumable products.
• 23andMe: Direct-to-consumer genetic testing company offering health predisposition and wellness reports. Comparable as a competitor in the consumer DNA testing space, though 23andMe lacks Endocanna's endocannabinoid specialization.
• Color Genomics: Clinical-grade genetic testing company with a provider portal and population health programs. Comparable on B2B provider sales of genetic tests and CLIA-certified lab infrastructure.
• Helix: DNA testing platform offering white-label and partner-branded genetic tests through its marketplace. Highly comparable on the Lab-in-a-Box white-label distribution model and API-driven platform.

Broad incumbents

• GeneDx: Clinical genetics lab offering diagnostic and screening tests with provider channels. Comparable as a clinical lab infrastructure operator with PGx and genetic interpretation capabilities.
• Myriad Genetics: Established clinical genetic testing company with broad pharmacogenomics and disease-risk offerings. Comparable as a broader incumbent in clinical genomics and PGx that competes with Endocanna's provider-facing tests.
• Sema4: Genomic testing and informatics company with AI-driven clinical interpretation. Comparable on the AI-powered genomic analysis offering and provider portal model.

Emerging players

• SelfDecode: DNA analysis and wellness platform offering personalized health reports based on genetic data. Comparable as a smaller competitor in the consumer DNA wellness space with similar report-based delivery.
• Cannabis Strategic Ventures / Strainprint Technologies: Cannabis-focused data and analytics companies that combine strain/genetic data with consumer outcomes. Comparable as a niche player in cannabis personalization that intersects Endocanna's ECS specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/EndocannaH
• YouTubeyoutube.com/channel/UCRCNgL5Z08wdd03B2KxH7Cg
• Facebookfacebook.com/EndoCannahealth
• Instagraminstagram.com/endo.dna

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Endocanna Health